Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound: the FOXPRO trial
Background - Multiparametric magnetic resonance imaging (mpMRI)/transrectal ultrasound (TRUS) fusion-guided high-intensity focused ultrasound (HIFU) is a focal treatment option for MRI-visible localized prostate cancer (PCa). High-quality evidence regarding the clinical efficacy remains limited. - O...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
March 2023
|
| In: |
European urology focus
Year: 2023, Jahrgang: 9, Heft: 2, Pages: 283-290 |
| ISSN: | 2405-4569 |
| DOI: | 10.1016/j.euf.2022.10.006 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.euf.2022.10.006 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2405456922002346 
|
| Verfasserangaben: | Niklas Westhoff, Ramona Ernst, Karl-Friedrich Kowalewski, Fabian Derigs, Manuel Neuberger, Dominik Nörenberg, Zoran V. Popovic, Manuel Ritter, Maurice Stephan Michel, Jost von Hardenberg |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1895736706 | ||
| 003 | DE-627 | ||
| 005 | 20241205153019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240718s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.euf.2022.10.006 |2 doi | |
| 035 | |a (DE-627)1895736706 | ||
| 035 | |a (DE-599)KXP1895736706 | ||
| 035 | |a (OCoLC)1475302826 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Westhoff, Niklas Christian |d 1988- |e VerfasserIn |0 (DE-588)107322306X |0 (DE-627)828672628 |0 (DE-576)434741752 |4 aut | |
| 245 | 1 | 0 | |a Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound |b the FOXPRO trial |c Niklas Westhoff, Ramona Ernst, Karl-Friedrich Kowalewski, Fabian Derigs, Manuel Neuberger, Dominik Nörenberg, Zoran V. Popovic, Manuel Ritter, Maurice Stephan Michel, Jost von Hardenberg |
| 264 | 1 | |c March 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 4. November 2022, Artikelversion: 29. März 2023 | ||
| 500 | |a Gesehen am 18.07.2024 | ||
| 520 | |a Background - Multiparametric magnetic resonance imaging (mpMRI)/transrectal ultrasound (TRUS) fusion-guided high-intensity focused ultrasound (HIFU) is a focal treatment option for MRI-visible localized prostate cancer (PCa). High-quality evidence regarding the clinical efficacy remains limited. - Objective - To assess medium-term oncological efficacy along with patient-reported outcome measures (PROMs). - Design, setting, and participants - This prospective single-center cohort study was performed from 2014 to 2020. Patients with primary International Society of Urological Pathologists (ISUP) grade group (GG) ≤2 by combined MRI/TRUS fusion and systematic prostate biopsy and prostate-specific antigen (PSA) <10 ng/ml were included. - Intervention - MRI/TRUS fusion-guided focal HIFU therapy. - Outcome measurements and statistical analysis - The primary outcome was the cancer-free rate of the HIFU-treated lesion by biopsy after 1 yr. Secondary endpoints included salvage treatment-free survival (STFS), metastasis-free survival (MFS), overall survival (OS), and PROMs according to International Consortium for Health Outcomes Measurement recommendations. - Results and limitations - Fifty patients were included (median [range] age 68 [48-80] yr; median PSA 6.5 [1.2-9.9] ng/ml; GG 1 54% [n = 27], and GG 2 46% [n = 23]). The median (range) PSA decrease from baseline to 12 mo was 51% (35.9-72.7%). In total, 37/50 patients (74%) underwent a 1-yr biopsy. PCa was detected in 23 patients (46%; GG 1 20% [n = 10]; GG >1 26% [n = 13]; infield 40% [n = 20]). At a median follow-up of 42 (13-73) mo, PCa was detected in 30 men (60%). Among all patients, 19 (38%) underwent salvage treatments (median [95% confidence interval] STFS 53 [44.3-61.7] mo). MFS and OS were 100% and 98%, respectively. The Expanded Prostate Cancer Index Composite-26 sexual domain decreased by 20.8 points (p = 0.372). - Conclusions - MRI/TRUS-guided focal HIFU therapy results in complete cancer ablation in only half of the treated patients after 1 yr, with further recurrences at medium-term follow-up. A decline of potency occurs in a subset of patients. - Patient summary - Focal image-guided high-intensity focused ultrasound therapy controls cancer in one of two patients. Its impact on urinary continence and erectile function is low. | ||
| 650 | 4 | |a High-intensity focused ultrasound ablation | |
| 650 | 4 | |a Multiparametric magnetic resonance imaging | |
| 650 | 4 | |a Prostatic neoplasms | |
| 650 | 4 | |a Quality of life | |
| 650 | 4 | |a Treatment outcome | |
| 700 | 1 | |a Ernst, Ramona |d 1988- |e VerfasserIn |0 (DE-588)1252530137 |0 (DE-627)1793900914 |4 aut | |
| 700 | 1 | |a Kowalewski, Karl-Friedrich |d 1989- |e VerfasserIn |0 (DE-588)1100724192 |0 (DE-627)859518825 |0 (DE-576)469770740 |4 aut | |
| 700 | 1 | |a Derigs, Fabian |d 1994- |e VerfasserIn |0 (DE-588)1298032172 |0 (DE-627)1854203487 |4 aut | |
| 700 | 1 | |a Neuberger, Manuel |e VerfasserIn |0 (DE-588)118332331X |0 (DE-627)1663137250 |4 aut | |
| 700 | 1 | |a Nörenberg, Dominik |e VerfasserIn |0 (DE-588)1064719996 |0 (DE-627)814432123 |0 (DE-576)424084228 |4 aut | |
| 700 | 1 | |a Popovic, Zoran V. |d 1974- |e VerfasserIn |0 (DE-588)134052390 |0 (DE-627)55988852X |0 (DE-576)277561051 |4 aut | |
| 700 | 1 | |a Ritter, Manuel |d 1979- |e VerfasserIn |0 (DE-588)1030329915 |0 (DE-627)73508436X |0 (DE-576)378128256 |4 aut | |
| 700 | 1 | |a Michel, Maurice Stephan |d 1970- |e VerfasserIn |0 (DE-588)121842568 |0 (DE-627)705674134 |0 (DE-576)29291363X |4 aut | |
| 700 | 1 | |a Hardenberg, Jost von |d 1982- |e VerfasserIn |0 (DE-588)1020494328 |0 (DE-627)688149278 |0 (DE-576)360578241 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European urology focus |d Amsterdam : Elsevier, 2015 |g 9(2023), 2 vom: März, Seite 283-290 |h Online-Ressource |w (DE-627)863008194 |w (DE-600)2861750-2 |w (DE-576)474000001 |x 2405-4569 |7 nnas |a Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound the FOXPRO trial |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g number:2 |g month:03 |g pages:283-290 |g extent:8 |a Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound the FOXPRO trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.euf.2022.10.006 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2405456922002346 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240718 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1020494328 |a Hardenberg, Jost von |m 1020494328:Hardenberg, Jost von |d 60000 |e 60000PH1020494328 |k 0/60000/ |p 10 |y j | ||
| 998 | |g 121842568 |a Michel, Maurice Stephan |m 121842568:Michel, Maurice Stephan |d 60000 |d 63100 |e 60000PM121842568 |e 63100PM121842568 |k 0/60000/ |k 1/60000/63100/ |p 9 | ||
| 998 | |g 134052390 |a Popovic, Zoran V. |m 134052390:Popovic, Zoran V. |d 60000 |d 63400 |e 60000PP134052390 |e 63400PP134052390 |k 0/60000/ |k 1/60000/63400/ |p 7 | ||
| 998 | |g 1064719996 |a Nörenberg, Dominik |m 1064719996:Nörenberg, Dominik |d 60000 |d 62900 |e 60000PN1064719996 |e 62900PN1064719996 |k 0/60000/ |k 1/60000/62900/ |p 6 | ||
| 998 | |g 118332331X |a Neuberger, Manuel |m 118332331X:Neuberger, Manuel |d 60000 |e 60000PN118332331X |k 0/60000/ |p 5 | ||
| 998 | |g 1298032172 |a Derigs, Fabian |m 1298032172:Derigs, Fabian |d 60000 |e 60000PD1298032172 |k 0/60000/ |p 4 | ||
| 998 | |g 1100724192 |a Kowalewski, Karl-Friedrich |m 1100724192:Kowalewski, Karl-Friedrich |d 60000 |d 63100 |e 60000PK1100724192 |e 63100PK1100724192 |k 0/60000/ |k 1/60000/63100/ |p 3 | ||
| 998 | |g 1252530137 |a Ernst, Ramona |m 1252530137:Ernst, Ramona |d 910000 |d 910300 |e 910000PE1252530137 |e 910300PE1252530137 |k 0/910000/ |k 1/910000/910300/ |p 2 | ||
| 998 | |g 107322306X |a Westhoff, Niklas Christian |m 107322306X:Westhoff, Niklas Christian |d 60000 |d 63100 |e 60000PW107322306X |e 63100PW107322306X |k 0/60000/ |k 1/60000/63100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1895736706 |e 4552981331 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound","subtitle":"the FOXPRO trial","title":"Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound"}],"person":[{"family":"Westhoff","given":"Niklas Christian","role":"aut","display":"Westhoff, Niklas Christian"},{"family":"Ernst","display":"Ernst, Ramona","given":"Ramona","role":"aut"},{"family":"Kowalewski","given":"Karl-Friedrich","role":"aut","display":"Kowalewski, Karl-Friedrich"},{"family":"Derigs","display":"Derigs, Fabian","given":"Fabian","role":"aut"},{"family":"Neuberger","display":"Neuberger, Manuel","role":"aut","given":"Manuel"},{"family":"Nörenberg","given":"Dominik","role":"aut","display":"Nörenberg, Dominik"},{"family":"Popovic","display":"Popovic, Zoran V.","given":"Zoran V.","role":"aut"},{"display":"Ritter, Manuel","given":"Manuel","role":"aut","family":"Ritter"},{"family":"Michel","display":"Michel, Maurice Stephan","role":"aut","given":"Maurice Stephan"},{"family":"Hardenberg","role":"aut","given":"Jost von","display":"Hardenberg, Jost von"}],"name":{"displayForm":["Niklas Westhoff, Ramona Ernst, Karl-Friedrich Kowalewski, Fabian Derigs, Manuel Neuberger, Dominik Nörenberg, Zoran V. Popovic, Manuel Ritter, Maurice Stephan Michel, Jost von Hardenberg"]},"relHost":[{"name":{"displayForm":["European Association of Urology (EAU)"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Medium-term oncological efficacy and patient-reported outcomes after focal high-intensity focused ultrasound the FOXPRO trialEuropean urology focus","id":{"eki":["863008194"],"zdb":["2861750-2"],"issn":["2405-4569"]},"note":["Gesehen am 13. Juli 2016"],"origin":[{"publisher":"Elsevier","dateIssuedDisp":"[2015]-","publisherPlace":"Amsterdam"}],"recId":"863008194","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"European urology focus","title":"European urology focus"}],"part":{"year":"2023","text":"9(2023), 2 vom: März, Seite 283-290","volume":"9","issue":"2","extent":"8","pages":"283-290"},"language":["eng"],"pubHistory":["Volume 1, issue 1 (August 2015)-"]}],"note":["Online verfügbar: 4. November 2022, Artikelversion: 29. März 2023","Gesehen am 18.07.2024"],"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}],"id":{"eki":["1895736706"],"doi":["10.1016/j.euf.2022.10.006"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1895736706","origin":[{"dateIssuedDisp":"March 2023","dateIssuedKey":"2023"}]} | ||
| SRT | |a WESTHOFFNIMEDIUMTERM2023 | ||